Back to Search Start Over

Percutaneous closure of simple congenital heart diseases under echocardiographic guidance.

Authors :
Jiang Y
Luo F
Bu H
Source :
European journal of medical research [Eur J Med Res] 2023 Oct 07; Vol. 28 (1), pp. 408. Date of Electronic Publication: 2023 Oct 07.
Publication Year :
2023

Abstract

Congenital heart disease (CHD), birth defect with the highest incidence rates worldwide, and is mainly characterized by the abnormal internal structure of the heart or/and the anatomical structure of great vessels. In the past few decades, CHD repair surgery through standard median sternotomy incision combined with cardiopulmonary bypass (CPB) technology has been considered the gold standard for surgical correction of heart and great vessels. With the promotion and clinical application of interventional catheterization technology, transcatheter closure of CHD under radioactive radiation has gradually been recognized and applied. However, its radiation exposure and potential complications related to arteriovenous vessels still face challenges. In recent years, an increasing number of surgeons have explored new surgical procedures, for the safe and effective treatment of CHD, as far as possible to reduce surgical trauma, avoid radiation exposure, and improve the cosmetic effect. Therefore, on the premise of satisfactory exposure or guidance, how to integrate ultrasound and percutaneous interventional technology remained the focus of the exploration. This mini-review highlights and summarizes the signs of progress of ultrasound intervention in the last decade that have proven the effectiveness and operability of a well-established procedure for percutaneous closure of congenital heart diseases under echocardiographic guidance only. We discuss potential diseases that will benefit from this emerging procedure based on this progress. Owing to the crucial advantages played by this strategy in the treatment of CHD, better understanding and promotion of this less exploited field may contribute to the development of therapeutics targeting CHD, improve medical utilization rate, promote the optimization of medical resources, and ultimately achieve precise and efficient medical treatment.<br /> (© 2023. BioMed Central Ltd., part of Springer Nature.)

Details

Language :
English
ISSN :
2047-783X
Volume :
28
Issue :
1
Database :
MEDLINE
Journal :
European journal of medical research
Publication Type :
Academic Journal
Accession number :
37805534
Full Text :
https://doi.org/10.1186/s40001-023-01398-8